|
NL6815872A
(enExample)
|
1967-11-22 |
1969-05-27 |
|
|
|
JPS5614663B2
(enExample)
|
1971-08-21 |
1981-04-06 |
|
|
|
US4582833A
(en)
|
1984-04-16 |
1986-04-15 |
American Cyanamid Company |
2-(substituted-1-piperazinyl)[1,2,4]triazolo[1,5-a]pyrimidines
|
|
US4576943A
(en)
|
1984-10-09 |
1986-03-18 |
American Cyanamid Company |
Pyrazolo[1,5-a]pyrimidines
|
|
US5308852A
(en)
|
1992-06-29 |
1994-05-03 |
Merck Frosst Canada, Inc. |
Heteroarylnaphthalenes as inhibitors of leukotriene biosynthesis
|
|
US6506876B1
(en)
|
1994-10-11 |
2003-01-14 |
G.D. Searle & Co. |
LTA4 hydrolase inhibitor pharmaceutical compositions and methods of use
|
|
DK0880363T3
(da)
|
1996-02-13 |
2003-01-20 |
Searle & Co |
Kombinationer der omfatter en cyclooxygenase-2 hæmmer samt en leukotrien A4 hydrolasehæmmer, som har immunsuppressive virkninger
|
|
US5952349A
(en)
|
1996-07-10 |
1999-09-14 |
Schering Corporation |
Muscarinic antagonists for treating memory loss
|
|
US6309561B1
(en)
|
1997-12-24 |
2001-10-30 |
3M Innovative Properties Company |
Liquid crystal compounds having a chiral fluorinated terminal portion
|
|
US6380203B1
(en)
*
|
1998-01-14 |
2002-04-30 |
Merck & Co., Inc. |
Angiogenesis inhibitors
|
|
GB9815880D0
(en)
|
1998-07-21 |
1998-09-16 |
Pfizer Ltd |
Heterocycles
|
|
GB9919776D0
(en)
|
1998-08-31 |
1999-10-27 |
Zeneca Ltd |
Compoujnds
|
|
AR023659A1
(es)
|
1998-09-18 |
2002-09-04 |
Vertex Pharma |
Un compuesto inhibidor de p38, una composicion farmaceutica que lo comprende y el uso de dicha composicion en el tratamiento y prevencion de estados patologicos
|
|
US6699873B1
(en)
|
1999-08-04 |
2004-03-02 |
Millennium Pharmaceuticals, Inc. |
Melanocortin-4 receptor binding compounds and methods of use thereof
|
|
US6924313B1
(en)
|
1999-09-23 |
2005-08-02 |
Pfizer Inc. |
Substituted tertiary-heteroalkylamines useful for inhibiting cholesteryl ester transfer protein activity
|
|
US6800651B2
(en)
|
2000-02-03 |
2004-10-05 |
Eli Lilly And Company |
Potentiators of glutamate receptors
|
|
US6552023B2
(en)
|
2000-02-22 |
2003-04-22 |
Cv Therapeutics, Inc. |
Aralkyl substituted piperazine compounds
|
|
US6451798B2
(en)
|
2000-02-22 |
2002-09-17 |
Cv Therapeutics, Inc. |
Substituted alkyl piperazine derivatives
|
|
JP2001354657A
(ja)
|
2000-06-09 |
2001-12-25 |
Sds Biotech:Kk |
置換ピペラジン誘導体及び農園芸用殺菌剤
|
|
DE60114518T2
(de)
|
2000-07-06 |
2006-08-10 |
Fuji Photo Film Co. Ltd., Minamiashigara |
Flüssigkristallzusammensetzung, die Flüssigkristallmoleküle und Ausrichtungsmittel enthält
|
|
WO2002064211A1
(en)
|
2001-02-09 |
2002-08-22 |
Merck & Co., Inc. |
Thrombin inhibitors
|
|
JP4365094B2
(ja)
|
2001-03-02 |
2009-11-18 |
メルク フロスト カナダ リミテツド |
カテプシンシステインプロテアーゼ阻害薬
|
|
AUPR362001A0
(en)
|
2001-03-08 |
2001-04-05 |
Fujisawa Pharmaceutical Co., Ltd. |
New compound
|
|
FR2826011B1
(fr)
|
2001-06-14 |
2004-12-10 |
Oreal |
Nouveaux derives de la 7-oxo-dhea et utilisation cosmetique
|
|
SE0102616D0
(sv)
|
2001-07-25 |
2001-07-25 |
Astrazeneca Ab |
Novel compounds
|
|
US6869975B2
(en)
|
2001-09-14 |
2005-03-22 |
Tularik Inc. |
Linked biaryl compounds
|
|
AU2002363236A1
(en)
|
2001-10-30 |
2003-05-12 |
Millennium Pharmaceuticals, Inc. |
Compounds, pharmaceutical compositions and methods of use therefor
|
|
US7851486B2
(en)
|
2002-10-17 |
2010-12-14 |
Decode Genetics Ehf. |
Susceptibility gene for myocardial infarction, stroke, and PAOD; methods of treatment
|
|
AU2003290527A1
(en)
|
2002-10-17 |
2004-05-04 |
Decode Genetics Ehf. |
Susceptibility gene for myocardial infarction
|
|
AU2003300360A1
(en)
|
2002-12-20 |
2004-07-22 |
Migenix Corp. |
Ligands of adenine nucleotide translocase (ant) and compositions and methods related thereto
|
|
EP1611902A4
(en)
|
2003-04-03 |
2006-04-12 |
Kyowa Hakko Kogyo Kk |
MEANS FOR THE PREVENTION AND / OR TREATMENT OF NEUROPATHIC PAIN
|
|
US7115642B2
(en)
|
2003-05-02 |
2006-10-03 |
Rigel Pharmaceuticals, Inc. |
Substituted diphenyl isoxazoles, pyrazoles and oxadiazoles useful for treating HCV infection
|
|
JP2005008581A
(ja)
*
|
2003-06-20 |
2005-01-13 |
Kissei Pharmaceut Co Ltd |
新規なピラゾロ［１，５−ａ］ピリミジン誘導体、それを含有する医薬組成物およびそれらの用途
|
|
PT1660491E
(pt)
|
2003-07-28 |
2008-10-10 |
Janssen Pharmaceutica Nv |
Derivados de benzimidazole, benzotiazole e benzoxazole e a sua utilização como moduladores de lta4h
|
|
EP1670445A2
(en)
|
2003-09-17 |
2006-06-21 |
Decode Genetics EHF. |
Methods of preventing or treating recurrence of myocardial infarction
|
|
DE10356579A1
(de)
*
|
2003-12-04 |
2005-07-07 |
Merck Patent Gmbh |
Aminderivate
|
|
SE0303480D0
(sv)
|
2003-12-19 |
2003-12-19 |
Biovitrum Ab |
Benzofuranes
|
|
EP1713809B1
(en)
|
2004-02-04 |
2009-07-29 |
Neurosearch A/S |
Dimeric azacyclic compounds and their use
|
|
WO2006033795A2
(en)
*
|
2004-09-17 |
2006-03-30 |
Wyeth |
Substituted pyrazolo [1, 5-a] pyrimidines for inhibiting abnormal cell growth
|
|
EP1868605A2
(en)
|
2005-03-31 |
2007-12-26 |
Janssen Pharmaceutica, N.V. |
Phenyl and pyridyl lta4h modulators
|
|
GB0514018D0
(en)
|
2005-07-07 |
2005-08-17 |
Ionix Pharmaceuticals Ltd |
Chemical compounds
|
|
EA017618B1
(ru)
|
2005-09-21 |
2013-01-30 |
Декод Дженетикс Ехф |
Биарилзамещенные гетероциклические ингибиторы lta4h для лечения воспаления
|
|
CN1947717B
(zh)
|
2005-10-14 |
2012-09-26 |
卓敏 |
选择性抑制腺苷酸环化酶1的化合物在制备用于治疗神经性疼痛和炎性疼痛的药物中的应用
|
|
DE102005049954A1
(de)
|
2005-10-19 |
2007-05-31 |
Sanofi-Aventis Deutschland Gmbh |
Triazolopyridin-derivate als Inhibitoren von Lipasen und Phospholipasen
|
|
EP1976828B1
(en)
|
2005-12-29 |
2016-12-21 |
Celtaxsys, Inc. |
Diamine derivatives as inhibitors of leukotriene a4 hydrolase
|
|
AU2007215247B2
(en)
|
2006-02-10 |
2012-12-13 |
Transtech Pharma, Llc |
Benzazole derivatives, compositions, and methods of use as Aurora kinase inhibitors
|
|
US20100029619A1
(en)
*
|
2006-08-04 |
2010-02-04 |
Takeda Pharmaceutical Company Limted |
Fused heterocyclic compound
|
|
DE602007005671D1
(de)
|
2006-10-19 |
2010-05-12 |
Hoffmann La Roche |
Aminomethyl-2-imidazole mit affinität zu mit dem trace-amin assoziierten rezeptoren
|
|
LT2121636T
(lt)
|
2006-12-14 |
2017-05-10 |
Janssen Pharmaceutica N.V. |
Piperazinilo ir diazepanilo benzamido darinių gamybos būdas
|
|
FR2911140B1
(fr)
|
2007-01-05 |
2009-02-20 |
Sanofi Aventis Sa |
Nouveaux derives de 2-anilino 4-heteroaryle pyrimides, leur preparation a titre de medicaments, compositions pharmaceutiques et notamment comme inhibiteurs de ikk
|
|
FR2911138B1
(fr)
|
2007-01-05 |
2009-02-20 |
Sanofi Aventis Sa |
Nouveaux derives de n, n'-2,4-dianilinopyrimidines, leur preparation a titre de medicaments, compositions pharmaceutiques et notamment comme inhibiteurs de ikk
|
|
FR2911139A1
(fr)
|
2007-01-05 |
2008-07-11 |
Sanofi Aventis Sa |
Nouveaux derives de phenyl-(4-phenyl-pyrimidin-2-yl)amines, leur preparation a titre de medicaments, compositions pharmaceutiques et notamment comme inhibiteurs de ikk
|
|
CA2691662A1
(en)
|
2007-07-02 |
2009-01-08 |
F. Hoffmann-La Roche Ag |
Imidazole derivatives as ccr2 receptor antagonists
|
|
KR20100098683A
(ko)
|
2007-12-12 |
2010-09-08 |
아스트라제네카 아베 |
펩티딜 니트릴, 및 디펩티딜 펩티다제 ｉ 억제제로서의 그의 용도
|
|
BRPI0908529A2
(pt)
*
|
2008-02-26 |
2015-09-29 |
Novartis Ag |
composto orgânicos
|
|
US20100029657A1
(en)
|
2008-02-29 |
2010-02-04 |
Wyeth |
Bridged, Bicyclic Heterocyclic or Spiro Bicyclic Heterocyclic Derivatives of Pyrazolo[1, 5-A]Pyrimidines, Methods for Preparation and Uses Thereof
|
|
EP2110374A1
(en)
|
2008-04-18 |
2009-10-21 |
Merck Sante |
Benzofurane, benzothiophene, benzothiazol derivatives as FXR modulators
|
|
WO2010011912A1
(en)
|
2008-07-25 |
2010-01-28 |
Smithkline Beecham Corporation |
Trpv4 antagonists
|
|
CN102030700B
(zh)
|
2009-09-30 |
2016-06-01 |
中国医学科学院药物研究所 |
苯甲酰胺基羧酸类化合物及其制法和药物用途
|
|
JP5781527B2
(ja)
|
2009-10-30 |
2015-09-24 |
ヤンセン ファーマシューティカ エヌ．ベー． |
４−置換−２−フェノキシ−フェニルアミンデルオピオイド受容体調節因子
|
|
EP2509982A1
(en)
|
2009-12-07 |
2012-10-17 |
Targacept, Inc. |
3,6-diazabicyclo[3.1.1]heptanes as neuronal nicotinic acetylcholine receptor ligands
|
|
KR101764952B1
(ko)
|
2010-07-29 |
2017-08-03 |
리겔 파마슈티칼스, 인크. |
Ａｍｐｋ-활성화 헤테로시클릭 화합물 및 그의 사용 방법
|
|
WO2012067822A1
(en)
*
|
2010-11-16 |
2012-05-24 |
Abbott Laboratories |
Pyrazolo [1, 5 -a] pyrimidin potassium channel modulators
|
|
PH12013501882A1
(en)
|
2011-03-15 |
2013-10-14 |
Rib X Pharmaceuticals Inc |
Antimicrobial agents
|
|
WO2012162407A1
(en)
|
2011-05-23 |
2012-11-29 |
Janssen Pharmaceutica Nv |
Picolinamido - propanoic acid derivatives useful as glucagon receptor antagonists
|
|
CN103159742B
(zh)
|
2011-12-16 |
2015-08-12 |
北京韩美药品有限公司 |
5-氯嘧啶类化合物及其作为egfr酪氨酸激酶抑制剂的应用
|
|
US9006235B2
(en)
*
|
2012-03-06 |
2015-04-14 |
Bristol-Myers Squibb Company |
Inhibitors of human immunodeficiency virus replication
|
|
ES2864862T3
(es)
|
2013-03-12 |
2021-10-14 |
Celltaxis Llc |
Métodos de inhibición de la leucotrieno A4 hidrolasa
|
|
CA2906086A1
(en)
|
2013-03-14 |
2014-09-25 |
Celtaxsys, Inc. |
Inhibitors of leukotriene a4 hydrolase
|
|
MX2015011677A
(es)
|
2013-03-14 |
2016-07-08 |
Celtaxsys Inc |
Inhibidores de leucotrieno a4 hidrolasa.
|